September 18, 2020
January 13, 2021
This week’s newsletter covers the Raising Capital During COVID-19 webinar, featured new member Jeffrey J. Kimbell & Associates, iVeena, a Salt Lake City-based biopharmaceutical company with a focus on unmet needs in ophthalmology, announcing the successful completion of Series B financing, IONIQ Sciences being listed in HS&M magazine’s 50 Top Med Tech Companies publication, and more.
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize
